Page last updated: 2024-08-23

idarubicin and fibrinogen

idarubicin has been researched along with fibrinogen in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Avvisati, G; Castaman, G; De Sanctis, V; Di Bona, E; Luce Vegna, M; Mandelli, F; Rodeghiero, F	1
Al Mohareb, F; Al Qurashi, F; Al Shanqeeti, A; Al Sharif, F; Al Zahrani, H; Aljurf, M; Chaudhri, N; Iqbal, A; Nurgat, ZA; Owaidah, T; Sahovic, E; Sanz, M; Zaidi, SZ	1
Farah, RA; Farhat, HZ; Jalkh, KS; Kadri, AM; Sayad, PE	1

Trials

1 trial(s) available for idarubicin and fibrinogen

Article	Year
High efficacy and low toxicity of APL induction with concurrent idarubicin/ATRA followed by a novel and simplified outpatient post-remission therapy using single doses of idarubicin and intermittent ATRA. Medical oncology (Northwood, London, England), 2010, Volume: 27, Issue:3 Topics: Adolescent; Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Dexamethasone; Disease-Free Survival; Drug Administration Schedule; Factor VIII; Female; Fibrinogen; Hemorrhage; Humans; Idarubicin; Kaplan-Meier Estimate; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Pilot Projects; Remission Induction; Tretinoin; Young Adult	2010

Article

Year

High efficacy and low toxicity of APL induction with concurrent idarubicin/ATRA followed by a novel and simplified outpatient post-remission therapy using single doses of idarubicin and intermittent ATRA.

Medical oncology (Northwood, London, England), 2010, Volume: 27, Issue:3

Topics: Adolescent; Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Dexamethasone; Disease-Free Survival; Drug Administration Schedule; Factor VIII; Female; Fibrinogen; Hemorrhage; Humans; Idarubicin; Kaplan-Meier Estimate; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Pilot Projects; Remission Induction; Tretinoin; Young Adult

2010

Other Studies

2 other study(ies) available for idarubicin and fibrinogen

Article	Year
Early haemorrhagic morbidity and mortality during remission induction with or without all-trans retinoic acid in acute promyelocytic leukaemia. British journal of haematology, 2000, Volume: 108, Issue:4 Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Child; Child, Preschool; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Fibrinogen; Hemorrhage; Humans; Idarubicin; Incidence; Infant; Italy; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Morbidity; Multivariate Analysis; Platelet Count; Prospective Studies; Remission Induction; Time Factors; Tretinoin	2000
Acquired protein C deficiency in a child with acute myelogenous leukemia, splenic, renal, and intestinal infarction. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2011, Volume: 22, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cholecystectomy; Cytarabine; Etoposide; Fibrin Fibrinogen Degradation Products; Fibrinogen; Gallbladder; Heparin, Low-Molecular-Weight; Humans; Idarubicin; Infarction; Kidney; Lebanon; Leukemia, Myeloid, Acute; Male; Protein C; Protein C Deficiency; Remission Induction; Splenectomy; Splenic Infarction; Thrombosis; Tretinoin	2011

Article

Year

Early haemorrhagic morbidity and mortality during remission induction with or without all-trans retinoic acid in acute promyelocytic leukaemia.

British journal of haematology, 2000, Volume: 108, Issue:4

Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Child; Child, Preschool; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Fibrinogen; Hemorrhage; Humans; Idarubicin; Incidence; Infant; Italy; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Morbidity; Multivariate Analysis; Platelet Count; Prospective Studies; Remission Induction; Time Factors; Tretinoin

2000

Acquired protein C deficiency in a child with acute myelogenous leukemia, splenic, renal, and intestinal infarction.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2011, Volume: 22, Issue:2

Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cholecystectomy; Cytarabine; Etoposide; Fibrin Fibrinogen Degradation Products; Fibrinogen; Gallbladder; Heparin, Low-Molecular-Weight; Humans; Idarubicin; Infarction; Kidney; Lebanon; Leukemia, Myeloid, Acute; Male; Protein C; Protein C Deficiency; Remission Induction; Splenectomy; Splenic Infarction; Thrombosis; Tretinoin

2011